Gregory Bristol

1.1k total citations
18 papers, 880 citations indexed

About

Gregory Bristol is a scholar working on Virology, Genetics and Immunology. According to data from OpenAlex, Gregory Bristol has authored 18 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Virology, 8 papers in Genetics and 8 papers in Immunology. Recurrent topics in Gregory Bristol's work include HIV Research and Treatment (11 papers), Virus-based gene therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). Gregory Bristol is often cited by papers focused on HIV Research and Treatment (11 papers), Virus-based gene therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). Gregory Bristol collaborates with scholars based in United States, France and Netherlands. Gregory Bristol's co-authors include Jerome A. Zack, Dimitrios N. Vatakis, Sohn G. Kim, Irvin S. Y. Chen, Grace M. Aldrovandi, Yiming Xie, Kouki Morizono, Lianying Gao, Sean Burke and David N. Levy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

In The Last Decade

Gregory Bristol

18 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory Bristol United States	14	462	367	293	273	213	18	880
Si‐Hua Mao United States	7	495 1.1×	335 0.9×	279 1.0×	126 0.5×	222 1.0×	8	728
Michelle Connole United States	14	275 0.6×	507 1.4×	219 0.7×	132 0.5×	96 0.5×	22	874
Younong Xu United States	15	289 0.6×	449 1.2×	308 1.1×	127 0.5×	198 0.9×	22	877
Dimitrios N. Vatakis United States	15	382 0.8×	298 0.8×	139 0.5×	106 0.4×	179 0.8×	23	646
Takashi Odawara Japan	15	316 0.7×	210 0.6×	239 0.8×	85 0.3×	164 0.8×	46	704
Alberto C. Guardo Spain	14	393 0.9×	406 1.1×	241 0.8×	63 0.2×	237 1.1×	31	794
Robert C. Gallo United States	13	348 0.8×	232 0.6×	220 0.8×	93 0.3×	202 0.9×	17	817
Elana S. Ehrlich United States	15	754 1.6×	398 1.1×	466 1.6×	121 0.4×	499 2.3×	19	1.2k
Thomas M. J. Niederman United States	9	414 0.9×	226 0.6×	170 0.6×	86 0.3×	217 1.0×	10	590
Ramu A. Subbramanian United States	17	756 1.6×	445 1.2×	471 1.6×	99 0.4×	459 2.2×	23	1.1k

Countries citing papers authored by Gregory Bristol

Since Specialization

Citations

This map shows the geographic impact of Gregory Bristol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Bristol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Bristol more than expected).

Fields of papers citing papers by Gregory Bristol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Bristol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Bristol. The network helps show where Gregory Bristol may publish in the future.

Co-authorship network of co-authors of Gregory Bristol

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Bristol. A scholar is included among the top collaborators of Gregory Bristol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Bristol. Gregory Bristol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Vatakis, Dimitrios N., Arumugam Balamurugan, Sohn G. Kim, et al.. (2013). Introduction of Exogenous T-cell Receptors Into Human Hematopoietic Progenitors Results in Exclusion of Endogenous T-cell Receptor Expression. Molecular Therapy. 21(5). 1055–1063. 33 indexed citations

2.

Dadachova, Ekaterina, Scott G. Kitchen, Gregory Bristol, et al.. (2012). Pre-Clinical Evaluation of a 213Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication. PLoS ONE. 7(3). e31866–e31866. 27 indexed citations

3.

Kitchen, Scott G., Bernard Levin, Gregory Bristol, et al.. (2012). In Vivo Suppression of HIV by Antigen Specific T Cells Derived from Engineered Hematopoietic Stem Cells. PLoS Pathogens. 8(4). e1002649–e1002649. 68 indexed citations

4.

Vatakis, Dimitrios N., Gregory Bristol, Sohn G. Kim, et al.. (2012). Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model. Journal of Visualized Experiments. e4181–e4181. 27 indexed citations

5.

Vatakis, Dimitrios N., Gregory Bristol, Sohn G. Kim, et al.. (2012). Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model. Journal of Visualized Experiments. 9 indexed citations

6.

Dadachova, Ekaterina, Scott G. Kitchen, Gregory Bristol, et al.. (2012). Correction: Pre-Clinical Evaluation of a²¹³Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication. PLoS ONE. 7(8). 4 indexed citations

7.

Marsden, Matthew D., Michael Kovochich, Nuttee Suree, et al.. (2011). HIV Latency in the Humanized BLT Mouse. Journal of Virology. 86(1). 339–347. 93 indexed citations

8.

Vatakis, Dimitrios N., Richard C. Koya, Christopher C. Nixon, et al.. (2011). Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells. Proceedings of the National Academy of Sciences. 108(51). E1408–16. 85 indexed citations

9.

Vatakis, Dimitrios N., Christopher C. Nixon, Gregory Bristol, & Jerome A. Zack. (2009). Differentially Stimulated CD4⁺T Cells Display Altered Human Immunodeficiency Virus Infection Kinetics: Implications for the Efficacy of Antiviral Agents. Journal of Virology. 83(7). 3374–3378. 13 indexed citations

10.

Gelderblom, Huub C., et al.. (2008). Viral complementation allows HIV-1 replication without integration. Retrovirology. 5(1). 60–60. 90 indexed citations

11.

Burke, Bryan, Helen Brown, Matthew D. Marsden, et al.. (2007). Primary Cell Model for Activation-Inducible Human Immunodeficiency Virus. Journal of Virology. 81(14). 7424–7434. 29 indexed citations

12.

Vatakis, Dimitrios N., Gregory Bristol, Thomas A. Wilkinson, Samson A. Chow, & Jerome A. Zack. (2007). Immediate Activation Fails To Rescue Efficient Human Immunodeficiency Virus Replication in Quiescent CD4⁺T Cells. Journal of Virology. 81(7). 3574–3582. 56 indexed citations

13.

Amado, Rafael G., Ronald T. Mitsuyasu, Joseph D. Rosenblatt, et al.. (2004). Anti-Human Immunodeficiency Virus Hematopoietic Progenitor Cell-Delivered Ribozyme in a Phase I Study: Myeloid and Lymphoid Reconstitution in Human Immunodeficiency Virus Type-1–Infected Patients. Human Gene Therapy. 15(3). 251–262. 113 indexed citations

14.

Morizono, Kouki, et al.. (2001). Antibody-Directed Targeting of Retroviral Vectors via Cell Surface Antigens. Journal of Virology. 75(17). 8016–8020. 106 indexed citations

15.

Uíttenbogaart, Christel H., Wendy Law, Pieter J. M. Leenen, et al.. (1998). Thymic Dendritic Cells Are Primary Targets for the Oncogenic Virus SL3-3. Journal of Virology. 72(12). 10118–10125. 7 indexed citations

16.

Aldrovandi, Grace M., Lianying Gao, Gregory Bristol, & Jerome A. Zack. (1998). Regions of Human Immunodeficiency Virus Type 1 nef Required for Function In Vivo. Journal of Virology. 72(9). 7032–7039. 53 indexed citations

17.

Koka, Prasad S, John K. Fraser, Yvonne J. Bryson, et al.. (1998). Human Immunodeficiency Virus Inhibits Multilineage Hematopoiesis In Vivo. Journal of Virology. 72(6). 5121–5127. 57 indexed citations

18.

Bristol, Gregory, Lianying Gao, & Jerome A. Zack. (1997). Preparation and Maintenance of SCID-hu Mice for HIV Research. Methods. 12(4). 343–347. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact